Literature DB >> 2862900

Effects of nicardipine on coronary blood flow, left ventricular inotropic state and myocardial metabolism in patients with angina pectoris.

M F Rousseau, M F Vincent, P Cheron, G van den Berghe, A A Charlier, H Pouleur.   

Abstract

The effects of intravenous nicardipine (2.5 mg) on the left ventricular (LV) inotropic state, LV metabolism, and coronary haemodynamics were analysed in 22 patients with angina pectoris. Measurements were made at fixed heart rate (atrial pacing), under basal state, and during a cold pressor test. After nicardipine, coronary blood flow and oxygen content in the coronary sinus increased significantly. The indices of inotropic state increased slightly, and the rate of isovolumic LV pressure fall improved. Myocardial oxygen consumption was unchanged despite the significant reduction in pressure-rate product, but LV lactate uptake increased, particularly during the cold pressor test. When nicardipine was administered after propranolol, the indices of inotropic state were unaffected. The lack of direct effect of nicardipine on LV inotropic state was further confirmed by intracoronary injection of 0.1 and 0.2 mg in a separate group of 10 patients. It is concluded that the nicardipine-induced coronary dilatation seems to improve perfusion and aerobic metabolism in areas with chronic ischaemia, resulting in reduced lactate production and augmented oxygen consumption.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2862900      PMCID: PMC1400763          DOI: 10.1111/j.1365-2125.1985.tb05158.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  27 in total

1.  Measurement of coronary sinus blood flow by continuous thermodilution in man.

Authors:  W Ganz; K Tamura; H S Marcus; R Donoso; S Yoshida; H J Swan
Journal:  Circulation       Date:  1971-08       Impact factor: 29.690

2.  Mechanisms underlying the cardiovascular action of a new dihydropyridine vasodilator YC-93.

Authors:  K Satoh; T Yanagisawa; N Taira
Journal:  Clin Exp Pharmacol Physiol       Date:  1980 May-Jun       Impact factor: 2.557

3.  Effect of calcium antagonism on contractile behavior of canine hearts.

Authors:  R J Gelpi; S M Mosca; G J Rinaldi; A Kosoglov; H E Cingolani
Journal:  Am J Physiol       Date:  1983-03

4.  Impaired early left ventricular relaxation in coronary artery disease: effects of intracornary nifedipine.

Authors:  M F Rousseau; C Veriter; J M Detry; L Brasseur; H Pouleur
Journal:  Circulation       Date:  1980-10       Impact factor: 29.690

5.  Preferential uptake of lactate by the normal myocardium in dogs.

Authors:  A J Drake; J R Haines; M I Noble
Journal:  Cardiovasc Res       Date:  1980-02       Impact factor: 10.787

6.  Mechanism of relief of pacing induced angina with oral verapamil: reduced oxygen demand.

Authors:  J L Rouleau; K Chatterjee; T A Ports; M B Doyle; B Hiramatsu; W W Parmley
Journal:  Circulation       Date:  1983-01       Impact factor: 29.690

Review 7.  Diastolic pressure-volume relations in the diseased heart.

Authors:  W Grossman; W H Barry
Journal:  Fed Proc       Date:  1980-02

8.  Nifedipine in the treatment of unstable angina, coronary spasm and myocardial ischemia.

Authors:  P G Hugenholtz; H R Michels; P W Serruys; R W Brower
Journal:  Am J Cardiol       Date:  1981-01       Impact factor: 2.778

9.  Effect of nifedipine on exercise-induced left ventricular dysfunction and myocardial hypoperfusion in stable angina.

Authors:  N M Zacca; M S Verani; R A Chahine; R R Miller
Journal:  Am J Cardiol       Date:  1982-10       Impact factor: 2.778

10.  Therapy of coronary vasoconstriction in patients with coronary artery disease.

Authors:  S Gunther; J E Muller; G H Mudge; W Grossman
Journal:  Am J Cardiol       Date:  1981-01       Impact factor: 2.778

View more
  7 in total

1.  The cardiovascular effects of oral nifedipine and nicardipine: a double-blind comparison in healthy volunteers using transthoracic bioimpedance cardiography.

Authors:  S H Thomas; P Molyneux; J Kelly; S E Smith
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.

Authors:  D D Freedman; D D Waters
Journal:  Drugs       Date:  1987-11       Impact factor: 9.546

3.  The acute haemodynamic effects of nicardipine in patients with chronic left ventricular failure.

Authors:  R A Greenbaum; S Wan; T R Evans
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

Review 4.  Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold
Journal:  Drugs       Date:  1987-04       Impact factor: 9.546

5.  Comparison of the ability of nicardipine, theophylline and zaprinast to restore cardiovascular haemodynamics following inhibition of nitric oxide synthesis.

Authors:  N A Herity; J D Allen; B Silke; A A Adgey
Journal:  Br J Pharmacol       Date:  1994-06       Impact factor: 8.739

6.  Comparison of the cardiovascular effects of nifedipine and nicardipine in the presence of atenolol.

Authors:  S H Thomas
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

7.  Nicardipine versus nitroglycerin for hypertensive acute heart failure syndrome: a single-center observational study.

Authors:  Takatoshi Koroki; Tomohiro Abe; Hidenobu Ochiai
Journal:  J Rural Med       Date:  2022-01-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.